Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 706

1.

Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data.

Haase R, Schlattmann P, Gueret P, Andreini D, Pontone G, Alkadhi H, Hausleiter J, Garcia MJ, Leschka S, Meijboom WB, Zimmermann E, Gerber B, Schoepf UJ, Shabestari AA, Nørgaard BL, Meijs MFL, Sato A, Ovrehus KA, Diederichsen ACP, Jenkins SMM, Knuuti J, Hamdan A, Halvorsen BA, Mendoza-Rodriguez V, Rochitte CE, Rixe J, Wan YL, Langer C, Bettencourt N, Martuscelli E, Ghostine S, Buechel RR, Nikolaou K, Mickley H, Yang L, Zhang Z, Chen MY, Halon DA, Rief M, Sun K, Hirt-Moch B, Niinuma H, Marcus RP, Muraglia S, Jakamy R, Chow BJ, Kaufmann PA, Tardif JC, Nomura C, Kofoed KF, Laissy JP, Arbab-Zadeh A, Kitagawa K, Laham R, Jinzaki M, Hoe J, Rybicki FJ, Scholte A, Paul N, Tan SY, Yoshioka K, Röhle R, Schuetz GM, Schueler S, Coenen MH, Wieske V, Achenbach S, Budoff MJ, Laule M, Newby DE, Dewey M; COME-CCT Consortium.

BMJ. 2019 Jun 12;365:l1945. doi: 10.1136/bmj.l1945.

2.

Brief Report: SWOG S1400B (NCT02785913), A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).

Langer CJ, Redman MW, Wade JL 3rd, Aggarwal C, Bradley JD, Crawford J, Stella PJ, Knapp MH, Miao J, Minichiello K, Herbst RS, Kelly K, Gandara DR, Papadimitrakopoulou VA.

J Thorac Oncol. 2019 May 31. pii: S1556-0864(19)30414-9. doi: 10.1016/j.jtho.2019.05.029. [Epub ahead of print]

PMID:
31158500
3.

Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged Populations.

Singhi EK, Horn L, Sequist LV, Heymach J, Langer CJ.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:e187-e197. doi: 10.1200/EDBK_237821. Epub 2019 May 17.

PMID:
31099642
4.

Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Bagley SJ, Talento S, Mitra N, Meropol NJ, Cohen RB, Langer CJ, Vachani A.

J Natl Compr Canc Netw. 2019 May 1;17(5):469-477. doi: 10.6004/jnccn.2018.7102.

PMID:
31085759
5.

Approaching the Gamow Window with Stored Ions: Direct Measurement of ^{124}Xe(p,γ) in the ESR Storage Ring.

Glorius J, Langer C, Slavkovská Z, Bott L, Brandau C, Brückner B, Blaum K, Chen X, Dababneh S, Davinson T, Erbacher P, Fiebiger S, Gaßner T, Göbel K, Groothuis M, Gumberidze A, Gyürky G, Heil M, Hess R, Hensch R, Hillmann P, Hillenbrand PM, Hinrichs O, Jurado B, Kausch T, Khodaparast A, Kisselbach T, Klapper N, Kozhuharov C, Kurtulgil D, Lane G, Lederer-Woods C, Lestinsky M, Litvinov S, Litvinov YA, Löher B, Nolden F, Petridis N, Popp U, Rauscher T, Reed M, Reifarth R, Sanjari MS, Savran D, Simon H, Spillmann U, Steck M, Stöhlker T, Stumm J, Surzhykov A, Szücs T, Nguyen TT, Taremi Zadeh A, Thomas B, Torilov SY, Törnqvist H, Träger M, Trageser C, Trotsenko S, Varga L, Volknandt M, Weick H, Weigand M, Wolf C, Woods PJ, Xing YM.

Phys Rev Lett. 2019 Mar 8;122(9):092701. doi: 10.1103/PhysRevLett.122.092701.

PMID:
30932526
6.

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.

Gubens MA, Sequist LV, Stevenson JP, Powell SF, Villaruz LC, Gadgeel SM, Langer CJ, Patnaik A, Borghaei H, Jalal SI, Fiore J, Saraf S, Raftopoulos H, Gandhi L.

Lung Cancer. 2019 Apr;130:59-66. doi: 10.1016/j.lungcan.2018.12.015. Epub 2018 Dec 17.

PMID:
30885353
7.

Variance Between Different Light Obscuration and Flow Imaging Microscopy Instruments and the Impact of Instrument Calibration.

Matter A, Koulov A, Singh S, Mahler HC, Reinisch H, Langer C, Zucol B, Mathaes R.

J Pharm Sci. 2019 Mar 4. pii: S0022-3549(19)30135-2. doi: 10.1016/j.xphs.2019.02.019. [Epub ahead of print]

PMID:
30844365
8.

Relationship of exercise to coronary artery disease extent, severity and plaque type: A coronary computed tomography angiography study.

Feuchtner G, Langer C, Barbieri F, Beyer C, Dichtl W, Bonaros N, Cartes-Zumelzu F, Klauser A, Schachner T, Friedrich G, Plank F, Senoner T.

J Cardiovasc Comput Tomogr. 2019 Feb 27. pii: S1934-5925(18)30396-4. doi: 10.1016/j.jcct.2019.02.001. [Epub ahead of print]

PMID:
30837117
9.

Deep Into the Amplituhedron: Amplitude Singularities at All Loops and Legs.

Arkani-Hamed N, Langer C, Srikant AY, Trnka J.

Phys Rev Lett. 2019 Feb 8;122(5):051601. doi: 10.1103/PhysRevLett.122.051601.

PMID:
30821991
10.

Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.

Aggarwal C, Davis CW, Mick R, Thompson JC, Ahmed S, Jeffries S, Bagley S, Gabriel P, Evans TL, Bauml JM, Ciunci C, Alley E, Morrissette JJD, Cohen RB, Carpenter EL, Langer CJ.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00107. Epub 2018 Aug 31.

11.

Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma.

Thomsen H, Chattopadhyay S, Weinhold N, Vodicka P, Vodickova L, Hoffmann P, Nöthen MM, Jöckel KH, Langer C, Hajek R, Hallmans G, Pettersson-Kymmer U, Ohlsson C, Späth F, Houlston R, Goldschmidt H, Hemminki K, Försti A.

Leukemia. 2019 Feb 8. doi: 10.1038/s41375-019-0396-x. [Epub ahead of print] No abstract available.

PMID:
30737484
12.

A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.

Schnoll R, Leone F, Veluz-Wilkins A, Miele A, Hole A, Jao NC, Paul Wileyto E, Carroll AJ, Kalhan R, Patel J, Langer C, Lubitz SF, Hitsman B.

Psychooncology. 2019 Mar;28(3):561-569. doi: 10.1002/pon.4978. Epub 2019 Jan 24.

PMID:
30680852
13.

Non obstructive high-risk plaque but not calcified by coronary CTA, and the G-score predict ischemia.

Feuchtner GM, Barbieri F, Langer C, Beyer C, Widmann G, Friedrich GJ, Cartes-Zumelzu F, Plank F.

J Cardiovasc Comput Tomogr. 2019 Jan 4. pii: S1934-5925(18)30397-6. doi: 10.1016/j.jcct.2019.01.010. [Epub ahead of print]

PMID:
30661963
14.

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Went M, Sud A, Försti A, Halvarsson BM, Weinhold N, Kimber S, van Duin M, Thorleifsson G, Holroyd A, Johnson DC, Li N, Orlando G, Law PJ, Ali M, Chen B, Mitchell JS, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Bandapalli OR, Einsele H, Gregory WA, Gullberg U, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Johnsson E, Kristinsson SY, Mellqvist UH, Nahi H, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N; PRACTICAL consortium, Nickel J, Nöthen MM, Rafnar T, Ross FM, da Silva Filho MI, Thomsen H, Turesson I, Vangsted A, Andersen NF, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Goldschmidt H, Kaiser M, Sonneveld P, Stefansson K, Morgan GJ, Hemminki K, Nilsson B, Houlston RS.

Nat Commun. 2019 Jan 10;10(1):213. doi: 10.1038/s41467-018-08107-8.

15.

An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy.

Konski A, Bhargavan M, Owen J, Komaki R, Langer CJ, Gore E, Paulus R, Choy H, Bruner DW, Curran WJ.

J Radiat Oncol. 2018 Jun;7(2):195-201. doi: 10.1007/s13566-018-0346-7. Epub 2018 Mar 10.

16.

Formation of Si/organic interfaces using alkyne-functionalized cyclooctynes-precursor-mediated adsorption of linear alkynes versus direct adsorption of cyclooctyne on Si(0 0 1).

Länger C, Heep J, Nikodemiak P, Bohamud T, Kirsten P, Höfer U, Koert U, Dürr M.

J Phys Condens Matter. 2019 Jan 23;31(3):034001. doi: 10.1088/1361-648X/aaefc3.

PMID:
30523882
17.

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

Gadgeel SM, Stevenson JP, Langer CJ, Gandhi L, Borghaei H, Patnaik A, Villaruz LC, Gubens M, Hauke R, Yang JC, Sequist LV, Bachman R, Saraf S, Raftopoulos H, Papadimitrakopoulou V.

Lung Cancer. 2018 Nov;125:273-281. doi: 10.1016/j.lungcan.2018.08.019. Epub 2018 Aug 25.

PMID:
30429032
18.

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.

Bauml JM, Vinnakota R, Anna Park YH, Bates SE, Fojo T, Aggarwal C, Di Stefano J, Knepley C, Limaye S, Mamtani R, Wisnivesky J, Damjanov N, Langer CJ, Cohen RB, Sigel K.

Cancer. 2019 Feb 1;125(3):406-415. doi: 10.1002/cncr.31816. Epub 2018 Oct 20.

PMID:
30341983
19.

Letter to the editor concerning Perenc & Peczkowski's "cognitive and affective empathy among adolescent siblings of children with a physical disability".

Lindemann WB, Langer CD, Bärtl M.

Disabil Health J. 2019 Jan;12(1):4-5. doi: 10.1016/j.dhjo.2018.09.008. Epub 2018 Oct 9. No abstract available.

PMID:
30337245
20.

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.

Aggarwal C, Thompson JC, Black TA, Katz SI, Fan R, Yee SS, Chien AL, Evans TL, Bauml JM, Alley EW, Ciunci CA, Berman AT, Cohen RB, Lieberman DB, Majmundar KS, Savitch SL, Morrissette JJD, Hwang WT, Elenitoba-Johnson KSJ, Langer CJ, Carpenter EL.

JAMA Oncol. 2018 Oct 11. doi: 10.1001/jamaoncol.2018.4305. [Epub ahead of print]

PMID:
30325992
21.

Nonparticipation Selection Bias in the MOBI-Kids Study.

Turner MC, Gracia-Lavedan E, Momoli F, Langer CE, Castaño-Vinyals G, Kundi M, Maule M, Merletti F, Sadetzki S, Vermeulen R, Albert A, Alguacil J, Aragones N, Badia F, Bruchim R, Carretero G, Kojimahara N, Lacour B, Morales-Suarez-Varela M, Radon K, Remen T, Weinmann T, Yamaguchi N, Cardis E.

Epidemiology. 2019 Jan;30(1):145-153. doi: 10.1097/EDE.0000000000000932.

22.

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Bauml JM, Vinnakota R, Anna Park YH, Bates SE, Fojo T, Aggarwal C, Limaye S, Damjanov N, Di Stefano J, Ciunci C, Genden EM, Wisnivesky JP, Ferrandino R, Mamtani R, Langer CJ, Cohen RB, Sigel K.

J Natl Cancer Inst. 2019 May 1;111(5):490-497. doi: 10.1093/jnci/djy133.

PMID:
30239887
23.

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Went M, Sud A, Försti A, Halvarsson BM, Weinhold N, Kimber S, van Duin M, Thorleifsson G, Holroyd A, Johnson DC, Li N, Orlando G, Law PJ, Ali M, Chen B, Mitchell JS, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Bandapalli OR, Einsele H, Gregory WA, Gullberg U, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Johnsson E, Kristinsson SY, Mellqvist UH, Nahi H, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N, Nickel J, Nöthen MM, Rafnar T, Ross FM, da Silva Filho MI, Thomsen H, Turesson I, Vangsted A, Andersen NF, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Goldschmidt H, Kaiser M, Sonneveld P, Stefansson K, Morgan GJ, Hemminki K, Nilsson B, Houlston RS; PRACTICAL consortium.

Nat Commun. 2018 Sep 13;9(1):3707. doi: 10.1038/s41467-018-04989-w. Erratum in: Nat Commun. 2019 Jan 10;10(1):213.

24.

Cerebral Autosomal Dominant Arteriopathy (CADASIL) with cardiac involvement (ANOCA) and subcortical leukencephalopathy.

Langer C, Adukauskaite A, Plank F, Feuchtner G, Cartes-Zumelzu F.

J Cardiovasc Comput Tomogr. 2018 Aug 31. pii: S1934-5925(18)30185-0. doi: 10.1016/j.jcct.2018.08.005. [Epub ahead of print]

PMID:
30197288
25.

Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial.

Gridelli C, de Castro Carpeno J, Dingemans AC, Griesinger F, Grossi F, Langer C, Ohe Y, Syrigos K, Thatcher N, Das-Gupta A, Truman M, Donica M, Smoljanovic V, Bennouna J.

JAMA Oncol. 2018 Dec 1;4(12):e183486. doi: 10.1001/jamaoncol.2018.3486. Epub 2018 Dec 13.

PMID:
30177994
26.

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Borghaei H, Langer CJ, Gadgeel S, Papadimitrakopoulou VA, Patnaik A, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Jalal SI, Panwalkar A, Yang JC, Gubens M, Sequist LV, Awad MM, Fiore J, Saraf S, Keller SM, Gandhi L.

J Thorac Oncol. 2019 Jan;14(1):124-129. doi: 10.1016/j.jtho.2018.08.004. Epub 2018 Aug 21.

PMID:
30138764
27.

Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.

Chattopadhyay S, Thomsen H, da Silva Filho MI, Weinhold N, Hoffmann P, Nöthen MM, Marina A, Jöckel KH, Schmidt B, Pechlivanis S, Langer C, Goldschmidt H, Hemminki K, Försti A.

Mol Med. 2018 Jun 11;24(1):30. doi: 10.1186/s10020-018-0031-8.

28.

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.

Seider MJ, Pugh SL, Langer C, Wyatt G, Demas W, Rashtian A, Clausen CL, Derdel JD, Cleary SF, Peters CA, Ramalingam A, Clarkson JE, Tomblyn M, Rabinovitch RA, Kachnic LA, Berk LB; NRG Oncology.

Ann Nucl Med. 2018 Oct;32(8):553-560. doi: 10.1007/s12149-018-1278-4. Epub 2018 Aug 9.

PMID:
30094545
29.

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC.

Langer CJ, Kim ES, Anderson EC, Jotte RM, Modiano M, Haggstrom DE, Socoteanu MP, Smith DA, Dakhil C, Konduri K, Berry T, Ong TJ, Sanford A, Amiri K, Goldman JW, Weiss J; ABOUND.70+ Investigators.

Front Oncol. 2018 Jul 24;8:262. doi: 10.3389/fonc.2018.00262. eCollection 2018.

30.

Leptomeningeal Myelomatosis: A Rare but Devastating Manifestation of Multiple Myeloma Diagnosed Using Cytology, Flow Cytometry, and Fluorescent in situ Hybridization.

Bommer M, Kull M, Teleanu V, Schwarzwälder P, Feuring-Buske M, Kroenke J, Bunjes D, Langer C.

Acta Haematol. 2018;139(4):247-254. doi: 10.1159/000489484. Epub 2018 Jul 11.

31.

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.

Bonomi PD, Gandara D, Hirsch FR, Kerr KM, Obasaju C, Paz-Ares L, Bellomo C, Bradley JD, Bunn PA Jr, Culligan M, Jett JR, Kim ES, Langer CJ, Natale RB, Novello S, Pérol M, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Vansteenkiste JF, Wakelee H, Thatcher N.

Ann Oncol. 2018 Aug 1;29(8):1701-1709. doi: 10.1093/annonc/mdy196.

32.

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.

Hirsh V, Wan Y, Lin FJ, Margunato-Debay S, Ong TJ, Botteman M, Langer C.

Clin Lung Cancer. 2018 Sep;19(5):401-409.e4. doi: 10.1016/j.cllc.2018.04.023. Epub 2018 May 7.

33.

Factors influencing the induction of high affinity antibodies to Plasmodium falciparum merozoite antigens and how affinity changes over time.

Tijani MK, Reddy SB, Langer C, Beeson JG, Wahlgren M, Nwuba RI, Persson KEM.

Sci Rep. 2018 Jun 13;8(1):9026. doi: 10.1038/s41598-018-27361-w.

34.

Evaluation of right ventricular function by coronary computed tomography angiography using a novel automated 3D right ventricle volume segmentation approach: a validation study.

Burghard P, Plank F, Beyer C, Müller S, Dörler J, Zaruba MM, Pölzl L, Pölzl G, Klauser A, Rauch S, Barbieri F, Langer CE, Schgoer W, Williamson EE, Feuchtner G.

Eur Radiol. 2018 Dec;28(12):5129-5136. doi: 10.1007/s00330-018-5523-y. Epub 2018 Jun 4.

PMID:
29869175
35.

Correction to: Applicability and accuracy of pretest probability calculations implemented in the NICE clinical guideline for decision making about imaging in patients with chest pain of recent onset.

Roehle R, Wieske V, Schuetz GM, Gueret P, Andreini D, Meijboom WB, Pontone G, Garcia M, Alkadhi H, Honoris L, Hausleiter J, Bettencourt N, Zimmermann E, Leschka S, Gerber B, Rochitte C, Schoepf UJ, Shabestari AA, Nørgaard B, Sato A, Knuuti J, Meijs MFL, Brodoefel H, Jenkins SMM, Øvrehus KA, Diederichsen ACP, Hamdan A, Halvorsen BA, Rodriguez VM, Wan YL, Rixe J, Sheikh M, Langer C, Ghostine S, Martuscelli E, Niinuma H, Scholte A, Nikolaou K, Ulimoen G, Zhang Z, Mickley H, Nieman K, Kaufmann PA, Buechel RR, Herzog BA, Clouse M, Halon DA, Leipsic J, Bush D, Jakamy R, Sun K, Yang L, Johnson T, Laissy JP, Marcus R, Muraglia S, Tardif JC, Chow B, Paul N, Maintz D, Hoe J, de Roos A, Haase R, Laule M, Schlattmann P, Dewey M.

Eur Radiol. 2018 Nov;28(11):4919-4921. doi: 10.1007/s00330-018-5521-0.

PMID:
29858635
36.

Renovascular hypertension: endovascular therapy in complicated aortic Stanford type B dissection.

Cupa J, Hippe HJ, Schäfer P, Frey N, Langer C.

Cardiovasc Diagn Ther. 2018 Apr;8(2):173-175. doi: 10.21037/cdt.2017.11.06.

37.

Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria.

Bonomi P, Blumenthal G, Ferris AS, Stewart DJ, Selig WKD, Krug LM, Allen J, Ison G, Langer CJ, Melemed A, Odogwu L, Basu Roy U, Sandler A.

J Thorac Oncol. 2018 Jun;13(6):748-751. doi: 10.1016/j.jtho.2018.02.013. No abstract available.

38.

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

Hirsch FR, Kerr KM, Bunn PA Jr, Kim ES, Obasaju C, Pérol M, Bonomi P, Bradley JD, Gandara D, Jett JR, Langer CJ, Natale RB, Novello S, Paz-Ares L, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Stinchcombe TE, Vansteenkiste JF, Wakelee H, Thatcher N.

Clin Lung Cancer. 2018 Jul;19(4):331-339. doi: 10.1016/j.cllc.2018.03.014. Epub 2018 Mar 21. Review.

39.

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.

Camidge DR, Kim DW, Tiseo M, Langer CJ, Ahn MJ, Shaw AT, Huber RM, Hochmair MJ, Lee DH, Bazhenova LA, Gold KA, Ou SI, West HL, Reichmann W, Haney J, Clackson T, Kerstein D, Gettinger SN.

J Clin Oncol. 2018 Sep 10;36(26):2693-2701. doi: 10.1200/JCO.2017.77.5841. Epub 2018 May 16.

PMID:
29768119
40.

Strong Neutron Pairing in core+4n Nuclei.

Revel A, Marqués FM, Sorlin O, Aumann T, Caesar C, Holl M, Panin V, Vandebrouck M, Wamers F, Alvarez-Pol H, Atar L, Avdeichikov V, Beceiro-Novo S, Bemmerer D, Benlliure J, Bertulani CA, Boillos JM, Boretzky K, Borge MJG, Caamaño M, Casarejos E, Catford WN, Cederkäll J, Chartier M, Chulkov L, Cortina-Gil D, Cravo E, Crespo R, Datta Pramanik U, Díaz Fernández P, Dillmann I, Elekes Z, Enders J, Ershova O, Estradé A, Farinon F, Fraile LM, Freer M, Galaviz D, Geissel H, Gernhäuser R, Golubev P, Göbel K, Hagdahl J, Heftrich T, Heil M, Heine M, Heinz A, Henriques A, Ignatov A, Johansson HT, Jonson B, Kahlbow J, Kalantar-Nayestanaki N, Kanungo R, Kelic-Heil A, Knyazev A, Kröll T, Kurz N, Labiche M, Langer C, Le Bleis T, Lemmon R, Lindberg S, Machado J, Marganiec J, Movsesyan A, Nacher E, Najafi M, Nilsson T, Nociforo C, Paschalis S, Perea A, Petri M, Pietri S, Plag R, Reifarth R, Ribeiro G, Rigollet C, Röder M, Rossi D, Savran D, Scheit H, Simon H, Syndikus I, Taylor JT, Tengblad O, Thies R, Togano Y, Velho P, Volkov V, Wagner A, Weick H, Wheldon C, Wilson G, Winfield JS, Woods P, Yakorev D, Zhukov M, Zilges A, Zuber K.

Phys Rev Lett. 2018 Apr 13;120(15):152504. doi: 10.1103/PhysRevLett.120.152504.

PMID:
29756867
41.

Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.

Katz SI, Hammer M, Bagley SJ, Aggarwal C, Bauml JM, Thompson JC, Nachiappan AC, Simone CB 2nd, Langer CJ.

J Thorac Oncol. 2018 Jul;13(7):978-986. doi: 10.1016/j.jtho.2018.04.010. Epub 2018 May 5.

PMID:
29738824
42.

Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.

Leleu X, Masszi T, Bahlis NJ, Viterbo L, Baker B, Gimsing P, Maisnar V, Samoilova O, Rosiñol L, Langer C, Song K, Izumi T, Cleeland C, Berg D, Lin HM, Zhu Y, Skacel T, Moreau P, Richardson PG.

Am J Hematol. 2018 May 4. doi: 10.1002/ajh.25134. [Epub ahead of print]

43.

Recall of mobile phone usage and laterality in young people: The multinational Mobi-Expo study.

Goedhart G, van Wel L, Langer CE, de Llobet Viladoms P, Wiart J, Hours M, Kromhout H, Benke G, Bouka E, Bruchim R, Choi KH, Eng A, Ha M, Huss A, Kiyohara K, Kojimahara N, Krewski D, Lacour B, 't Mannetje A, Maule M, Migliore E, Mohipp C, Momoli F, Petridou ET, Radon K, Remen T, Sadetzki S, Sim M, Weinmann T, Cardis E, Vrijheid M, Vermeulen R.

Environ Res. 2018 Aug;165:150-157. doi: 10.1016/j.envres.2018.04.018. Epub 2018 Apr 26.

PMID:
29704776
44.

Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer.

Chu CY, Choi J, Eaby-Sandy B, Langer CJ, Lacouture ME.

Oncologist. 2018 Aug;23(8):891-899. doi: 10.1634/theoncologist.2017-0582. Epub 2018 Apr 12. Review.

PMID:
29650685
45.

A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy.

Gubens MA, Chuang JC, Akerley W, Langer CJ, Clément-Duchêne C, San Pedro-Salcedo M, Colevas AD, Dragnev K, Socinski MA, Wakelee HA.

J Thorac Dis. 2018 Jan;10(1):219-227. doi: 10.21037/jtd.2017.12.30.

46.

Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 Therapy.

Hammer M, Bagley S, Aggarwal C, Bauml J, Nachiappan AC, Simone CB 2nd, Langer C, Katz SI.

Curr Probl Diagn Radiol. 2019 Mar - Apr;48(2):142-147. doi: 10.1067/j.cpradiol.2018.01.005. Epub 2018 Jan 31.

PMID:
29573843
47.

Applicability and accuracy of pretest probability calculations implemented in the NICE clinical guideline for decision making about imaging in patients with chest pain of recent onset.

Roehle R, Wieske V, Schuetz GM, Gueret P, Andreini D, Meijboom WB, Pontone G, Garcia M, Alkadhi H, Honoris L, Hausleiter J, Bettencourt N, Zimmermann E, Leschka S, Gerber B, Rochitte C, Schoepf UJ, Shabestari AA, Nørgaard B, Sato A, Knuuti J, Meijs MFL, Brodoefel H, Jenkins SMM, Øvrehus KA, Diederichsen ACP, Hamdan A, Halvorsen BA, Mendoza Rodriguez V, Wan YL, Rixe J, Sheikh M, Langer C, Ghostine S, Martuscelli E, Niinuma H, Scholte A, Nikolaou K, Ulimoen G, Zhang Z, Mickley H, Nieman K, Kaufmann PA, Buechel RR, Herzog BA, Clouse M, Halon DA, Leipsic J, Bush D, Jakamy R, Sun K, Yang L, Johnson T, Laissy JP, Marcus R, Muraglia S, Tardif JC, Chow B, Paul N, Maintz D, Hoe J, de Roos A, Haase R, Laule M, Schlattmann P, Dewey M.

Eur Radiol. 2018 Sep;28(9):4006-4017. doi: 10.1007/s00330-018-5322-5. Epub 2018 Mar 19. Erratum in: Eur Radiol. 2018 Jun 1;:.

PMID:
29556770
48.

Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.

Aggarwal C, Haas AR, Metzger S, Aguilar LK, Aguilar-Cordova E, Manzanera AG, Gómez-Hernández G, Katz SI, Alley EW, Evans TL, Bauml JM, Cohen RB, Langer CJ, Albelda SM, Sterman DH.

Mol Ther. 2018 May 2;26(5):1198-1205. doi: 10.1016/j.ymthe.2018.02.015. Epub 2018 Feb 21.

49.

Evolving Federal and State Health Care Policy: Toward a More Integrated and Comprehensive Care-Delivery System for Children With Medical Complexity.

Langer CS, Antonelli RC, Chamberlain L, Pan RJ, Keller D.

Pediatrics. 2018 Mar;141(Suppl 3):S259-S265. doi: 10.1542/peds.2017-1284K. Review.

50.

Quasifree (p, 2p) Reactions on Oxygen Isotopes: Observation of Isospin Independence of the Reduced Single-Particle Strength.

Atar L, Paschalis S, Barbieri C, Bertulani CA, Díaz Fernández P, Holl M, Najafi MA, Panin V, Alvarez-Pol H, Aumann T, Avdeichikov V, Beceiro-Novo S, Bemmerer D, Benlliure J, Boillos JM, Boretzky K, Borge MJG, Caamaño M, Caesar C, Casarejos E, Catford W, Cederkall J, Chartier M, Chulkov L, Cortina-Gil D, Cravo E, Crespo R, Dillmann I, Elekes Z, Enders J, Ershova O, Estrade A, Farinon F, Fraile LM, Freer M, Galaviz Redondo D, Geissel H, Gernhäuser R, Golubev P, Göbel K, Hagdahl J, Heftrich T, Heil M, Heine M, Heinz A, Henriques A, Hufnagel A, Ignatov A, Johansson HT, Jonson B, Kahlbow J, Kalantar-Nayestanaki N, Kanungo R, Kelic-Heil A, Knyazev A, Kröll T, Kurz N, Labiche M, Langer C, Le Bleis T, Lemmon R, Lindberg S, Machado J, Marganiec-Gałązka J, Movsesyan A, Nacher E, Nikolskii EY, Nilsson T, Nociforo C, Perea A, Petri M, Pietri S, Plag R, Reifarth R, Ribeiro G, Rigollet C, Rossi DM, Röder M, Savran D, Scheit H, Simon H, Sorlin O, Syndikus I, Taylor JT, Tengblad O, Thies R, Togano Y, Vandebrouck M, Velho P, Volkov V, Wagner A, Wamers F, Weick H, Wheldon C, Wilson GL, Winfield JS, Woods P, Yakorev D, Zhukov M, Zilges A, Zuber K; R^{3}B Collaboration.

Phys Rev Lett. 2018 Feb 2;120(5):052501. doi: 10.1103/PhysRevLett.120.052501.

PMID:
29481189

Supplemental Content

Loading ...
Support Center